Three best practices to cultivate healthier, thriving communities

Managed care organizations are no strangers to alarming statistics about barriers to healthcare access. Nevertheless, the numbers are still astounding when laid out next to each other—especially for those residing in the rural United States. We can help cultivate healthier, thriving communities with the best practices below.

Labcorp laboratories participate in company’s first-ever honey tasting competition

Beekeeping is the buzz around a number of our sites, and recently Labcorp hosted its first ever honey tasting competition.

Labcorp Finalizes Acquisition of Select Assets of Invitae

Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases BURLINGTON, N.C. , Aug. 5, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets

Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx

PGDx elio™ plasma focus Dx is the industry's first and only kitted, pan-solid tumor liquid biopsy test that enables tumor mutation profiling – all from a simple blood draw BURLINGTON, N.C. , Aug. 2, 2024 /PRNewswire/ -- Labcorp  (NYSE: LH), a global leader of innovative and comprehensive laboratory

Labcorp Announces 2024 Second Quarter Results

Updates Full-Year Guidance Results from Continuing Operations for second quarter 2024 versus last year: Revenue: $3.22 billion versus $3.03 billion Diluted EPS: $2.43 versus $1.74 Adjusted EPS: $3.94 versus $3.42 Free Cash Flow: $432.9 million versus $58.2 million Updated Full-Year 2024 Guidance:

Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities

BURLINGTON, N.C. , and FREMONT, Calif. , July 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with Ultima Genomics to utilize its UG 100 TM sequencing solution and ppmSeq TM technology to

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C. , July 25, 2024 /PRNewswire/ -- Labcorp  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 13, 2024

How payers are reimagining cost strategies with lab services: Four Becker’s roundtable takeaways

During Becker’s Spring 2024 Payer Issues Roundtable, Labcorp’s Cameron Thomason, vice president for acute care services, hospitals and health systems, and Andrew Wirsul, vice president for payer solutions, moderated a discussion among a diverse group of payer executives about the evolution of lab services. The key themes that emerged are summarized below. 

System advisory re the Crowdstrike computer outage

Labcorp Earns Top Score on 2024 Disability Equality Index®

Labcorp (NYSE: LH), a leading global life sciences company, today announced it has been named a Best Place to Work for Disability Inclusion after earning the top score of 100 on the 2024 Disability Equality Index®.